corticosterone has been researched along with Bronchopulmonary Dysplasia in 2 studies
Bronchopulmonary Dysplasia: A chronic lung disease developed after OXYGEN INHALATION THERAPY or mechanical ventilation (VENTILATION, MECHANICAL) usually occurring in certain premature infants (INFANT, PREMATURE) or newborn infants with respiratory distress syndrome (RESPIRATORY DISTRESS SYNDROME, NEWBORN). Histologically, it is characterized by the unusual abnormalities of the bronchioles, such as METAPLASIA, decrease in alveolar number, and formation of CYSTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using a mouse model of neonatal respiratory distress syndrome (RDS), we demonstrate a central role for macrophage migration inhibitory factor (MIF) in lung maturation at the developmental stage when human neonates are most susceptible to RDS." | 1.35 | A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome. ( Aghai, ZH; Baugh, JA; Bazzy-Asaad, A; Bhandari, V; Bucala, RJ; Donnelly, SC; Dzuira, JD; Fan, J; Kettunen, M; Kevill, KA; Leng, L; McDonald, CL; Mizue, Y; O'Connor, CL; Reyes-Mugica, M, 2008) |
| "Bronchopulmonary dysplasia is caused by several factors." | 1.27 | [Clinical management of bronchopulmonary dysplasia]. ( Frank, HD; Schachinger, H; Schmid, H, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kevill, KA | 1 |
| Bhandari, V | 1 |
| Kettunen, M | 1 |
| Leng, L | 1 |
| Fan, J | 1 |
| Mizue, Y | 1 |
| Dzuira, JD | 1 |
| Reyes-Mugica, M | 1 |
| McDonald, CL | 1 |
| Baugh, JA | 1 |
| O'Connor, CL | 1 |
| Aghai, ZH | 1 |
| Donnelly, SC | 1 |
| Bazzy-Asaad, A | 1 |
| Bucala, RJ | 1 |
| Schachinger, H | 1 |
| Frank, HD | 1 |
| Schmid, H | 1 |
2 other studies available for corticosterone and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome.
Topics: Animals; Bronchopulmonary Dysplasia; Corticosterone; Disease Models, Animal; Humans; Infant, Newborn | 2008 |
[Clinical management of bronchopulmonary dysplasia].
Topics: Bronchopulmonary Dysplasia; Combined Modality Therapy; Corticosterone; Humans; Infant, Newborn; Prog | 1984 |